PHARMACOECONOMIC ESTIMATION OF IMMUNOHISTOCHEMICAL DIAGNOSTICS OF LYMPHOPROLIFERATIVE DISEASES
The analysis of immunohistochemical (IHC) study of lymphoproliferative diseases according to the data of the Vitebsk Regional Pathoanatomical Bureau was made. It was revealed that the number of cases which are undergone the morphological research annually was approximately equal. These data allow a purchase planning of the reagents required quantity. Non-Hodgkin's lymphoma was investigated by IHC method in 90% of cases. Thus the cost of the used reagents constituted 8,3% of the bought reagents cost.